Cardiovascular Health 2018
Almost a third of all deaths around the world are caused by cardiovascular disease (CVD) and, with an increasingly ageing population, it has never been more important to find ways to prevent, manage and cure it. The Cardiovascular Health report, published in The Times, explores the alarming link between CVD and other life-threatening conditions, such as kidney failure, the range of digital technologies revolutionising diagnosis and treatment, and the health benefits of being happy. It covers the leaps and bounds which have already been made in heartcare, and draws a heartening picture of what the future could hold. Also featured is an infographic exploring the lifestyle factors which can increase the risk of CVD
Please register to download
Please register to download this report. Registration is 100% free and provides access to all the latest insight and analysis shaping business today.
In association with
In this report
Sponsored content
-
Future of Finance 2022
As inflation and prices continue to rise, our Future of Finance report explores the other challenges and opportunities facing the sector. It explores how fintech could work in the metaverse, why the challenger bank may have had its day, how decentralised finance is changing the game and just what payments firms need to do to achieve carbon-neutrality
-
The Future of Infrastructure 2022
A changing climate, as well as the changing needs of a growing population, are creating pressures on global infrastructure. How, then, is the industry adapting?
-
Future COO 2022
Is it possible to balance agility with resilience? Which business functions produce the best operational leaders? And whose responsibility should ESG be really? Our Future COO report explores these, as well as how COOs can prepare for recession and how the CEO-COO relationship is changing
-
Future of Healthcare 2022
The UK's healthcare system is facing chronic challenges, from antiquated administrative systems to staff and capital shortages. How can the NHS effectively modernise and ease the blockage? Which technologies will help treat the underlying causes of inefficiency and unlock innovation? And what does recent legislation and legal action mean for patients and employers?